Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-dependent calcium channel subunits are the protein components that assemble to form voltage-gated calcium channels (VGCCs), transmembrane ion channels that mediate calcium entry in response to changes in membrane potential[1][2][5]. The pore-forming α1 subunit determines channel type (e.g., L-, N-, P/Q-, R-, T-type) and pharmacological properties, while auxiliary subunits (β, α2δ, γ) modulate channel expression, gating, and kinetics[1][3]. These channels are essential transducers linking electrical activity to physiological responses such as muscle contraction, neurotransmitter or hormone secretion, and gene expression[1][2][5]. Mutations or dysregulation in VGCC subunits are linked to channelopathies and represent therapeutic targets for drugs in multiple clinical indications, mainly in neurology and cardiology[1][2][4][5].
Inhibition or modulation of calcium ion influx by blocking or altering the function of α1 or auxiliary subunit[1][2]; Disruption of auxiliary subunit interactions to reduce cell surface expression or change channel kinetics[1][3]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-dependent calcium channel subunit (CaV subunit).